The European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Welsh Partners

Public Health Wales

International Partners

The European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Funding Source
The European Committee on Antimicrobial Susceptibility Testing and the British Society for Antimicrobial Chemotherapy
Wales
All Wales
WHO Region
Europe
Country of intervention
France, Germany, Norway, Sweden, United Kingdom
Scale
International
Project Focus
Research, Evidence
About the project
Description

The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is a standing committee jointly organized by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), European Center for Disease Prevention and Control (ECDC) and European national breakpoint committees. EUCAST deals with breakpoints and technical aspects of Public Health England no typic in vitro  antimicrobial susceptibility testing and functions as the breakpoint committee of EMA and ECDC. The Specialist Antimicrobial Chemotherapy Unit (SACU) performs susceptibility testing for EUCAST studies to support clinical breakpoint setting. As the UK national susceptibility testing laboratory, SACU collaborates with the equivalent European laboratory on all aspects of clinical breakpoint settings.

What does your project involve?

Development of susceptibility testing methods and guidelines as well as testing new technologies and developments.

Key outcomes

The unit is involved in two studies, developing the EUCAST susceptibility testing method bacteria, Neisseria gonorrhoeae and anaerobes, where no guidelines exist at present.